tiprankstipranks
Advertisement
Advertisement
Biomea Fusion Advances Phase 2 Add-On Therapy Trial in Ozempic-Treated Diabetes
PremiumCompany AnnouncementsBiomea Fusion Advances Phase 2 Add-On Therapy Trial in Ozempic-Treated Diabetes
30d ago
Biomea Fusion Advances Mid‑Stage Diabetes Trial, Adding a New Angle to the BMEA Investment Story
Premium
Company Announcements
Biomea Fusion Advances Mid‑Stage Diabetes Trial, Adding a New Angle to the BMEA Investment Story
30d ago
Biomea Fusion doses first patient in COVALENT-211, COVALENT-212 trials
Premium
The Fly
Biomea Fusion doses first patient in COVALENT-211, COVALENT-212 trials
1M ago
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference
PremiumCompany AnnouncementsBiomea Fusion Highlights Diabetes Pipeline at JPM Conference
4M ago
Biomea Fusion initiated with a Buy at Rodman & Renshaw
Premium
The Fly
Biomea Fusion initiated with a Buy at Rodman & Renshaw
4M ago
Biomea Fusion enters 2026 focused on icovamenib, BMF-650 milestones
Premium
The Fly
Biomea Fusion enters 2026 focused on icovamenib, BMF-650 milestones
4M ago
Biomea Fusion announces presentation of two posters for BMF-650, icovamenib
PremiumThe FlyBiomea Fusion announces presentation of two posters for BMF-650, icovamenib
6M ago
Biomea Fusion price target lowered to $12 from $16 at D. Boral Capital
Premium
The Fly
Biomea Fusion price target lowered to $12 from $16 at D. Boral Capital
6M ago
Biomea Fusion Inc. Reports Q3 2025 Financial Results
Premium
Company Announcements
Biomea Fusion Inc. Reports Q3 2025 Financial Results
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100